Buscar resultados de ensayos clínicos
Enteritis - 32 Studies Found
| Estado | Estudiar |
| Terminated |
Nombre del estudio: Campylobacter Enteritis and PI-BD: Dietary Reduction in Carbohydrates Condición:
Fecha: 2014-09-02 Intervenciones:
|
| Completed |
Nombre del estudio: Plasma Citrulline Concentration in Tropical Enteropathy Condición:
|
| Completed |
Nombre del estudio: Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment Condición:
|
| ACTIVE_NOT_RECRUITING |
Nombre del estudio: Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults Condición: Gastroenteritis Fecha: 2025-11-04 Intervenciones: HIL-214 |
| ACTIVE_NOT_RECRUITING |
Nombre del estudio: Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 49 Years of Age and 60 to 80 Years of Age. Condición: Norovirus Acute Gastroenteritis Fecha: 2025-11-04 Intervenciones: Sterile liquid for injection |
| ACTIVE_NOT_RECRUITING |
Nombre del estudio: Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines Condición: Gastroenteritis Fecha: 2025-11-04 Intervenciones: 2 injections - given at 4 months and the second at 6 months of age. |
| COMPLETED |
Nombre del estudio: Admission Pattern Among Children With Gastro-intestinal Infections Before and During the Covid-19 Pandemic Condición: Gastroenteritis Fecha: 2025-11-04 |
| COMPLETED |
Nombre del estudio: Phase I Norovirus Challenge Model Condición: Gastroenteritis Norovirus Fecha: 2025-11-04 Intervenciones: Subjects will be NPO (nothing by mouth) for at least 90 minutes followed by ingestion of 60 mL of a 2% sodium bicarbonate solution by mouth. 2 minutes |
| Completed |
Nombre del estudio: Associations of Fecal Bile Acid Profile and Intestinal Flora With Chronic Radiation Enteritis Condición: Radiation Enteritis Fecha: 2025-11-04 |
| COMPLETED |
Nombre del estudio: Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) Condición: Acute Gastroenteritis Fecha: 2025-11-04 Intervenciones: Active ingredients: recombinant ReNoV GI.1-VP1 protein, recombinant ReNoV GII.3-VP1 protein, recombinant ReNoV GII.4-VP1 protein and recombinant Re |